Candriam S.C.A. Idera Pharmaceuticals, Inc. Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$2.37 - $3.97 $687,300 - $1.15 Million	-290,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.77 - $9.38 $263,150 - $891,100	95,000 Added 48.72%	290,000 $803,000
Q3 2018 Nov 07, 2018	BUY	$5.53 - $11.36 $1.08 Million - $2.22 Million	195,000 New	195,000 $1.74 Million

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.